{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:40:02Z","timestamp":1750534802845,"version":"3.41.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hemangiopericytoma is a mesenchymal neoplasm that derives from pericytes surrounding the capillaries presenting overexpression of PSMA, which can be a source of pitfall in <jats:sup>68<\/jats:sup>Ga-PSMA-11 PET\/CT. We reported 2 cases with recurrent hemangiopericytoma grade III with high expression of <jats:sup>68<\/jats:sup>Ga-PSMA-11 in PET\/CT. Based on the performed examination, one of them received targeted \u03b1-therapy with the IV injection of <jats:sup>225<\/jats:sup>Ac-PSMA-617.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004769","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T05:01:03Z","timestamp":1690174863000},"page":"e431-e433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["68Ga\u2013Prostate-Specific Membrane Antigen PET\/CT in Imaging of Hemangiopericytoma"],"prefix":"10.1097","volume":"48","author":[{"given":"Jolanta","family":"Kunikowska","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, Medical University of Warsaw, Warsaw"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata E.","family":"Chrapko","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Medical University of Lublin, Lublin, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000658-194207000-00004","article-title":"Hemangiopericytoma: a vascular tumor featuring Zimmermann\u2019s pericytes","volume":"116","year":"1942","journal-title":"Ann Surg"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/RLU.0000000000003511","article-title":"Hemangioblastoma: an unsuspected pitfall in PSMA PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"2468320","DOI":"10.1155\/2020\/2468320","article-title":"Hemangiopericytoma: incidence, treatment, and prognosis analysis based on SEER database","volume":"2020","year":"2020","journal-title":"Biomed Res Int"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00259-020-05017-0","article-title":"[68 Ga]Ga-prostate-specific membrane antigen PET\/CT: a novel method for imaging patients with hepatocellular carcinoma","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/RLU.0000000000002806","article-title":"68Ga-prostate-specific membrane antigen-11 PET\/CT: a new imaging option for recurrent glioblastoma multiforme?","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/diagnostics12071665","article-title":"Diagnostic accuracy of PET\/CT or PET\/MRI using PSMA-targeting radiopharmaceuticals in high-grade gliomas: a systematic review and a bivariate meta-analysis","volume":"12","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/RLU.0000000000004486","article-title":"68Ga-prostate-specific membrane antigen PET\/CT in ovarian tumors: potential to differentiate benign and malignant tumors before surgery: a preliminary report","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00259-020-04715-z","article-title":"Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1007\/s00259-021-05433-w","article-title":"PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/RLU.0000000000003467","article-title":"68Ga-prostate-specific membrane antigen PET\/CT in sinonasal glomangiopericytoma-exploring theranostic avenues!","volume":"46","year":"2021","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:03:34Z","timestamp":1750532614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004769","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,7,22]]}}}